LY 219057
| Code | Size | Price |
|---|
| TAR-T27900-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
LY 219057 is a potent, competitive, and specific antagonist of CCK receptor on the exocrine pancreas.
CAS:
150351-93-2
Formula:
C23H17ClF3N3OS
Molecular Weight:
475.91
Purity:
0.98
SMILES:
FC(F)(F)c1cc(NC(=S)N2NC(=O)[C@@H]([C@H]2c2ccccc2)c2ccccc2)ccc1Cl
References
1. Akiyama T, Tachibana I, Otsuki M. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini. Int J Pancreatol. 1993 Oct;14(2):167-73. PubMed PMID: 7506744.